藥明生物(02269.HK)獲摩根大通增持279.13萬股

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

藥明生物(02269.HK)獲摩根大通增持279.13萬股

格隆匯 01-11 07:44

格隆匯APP獲悉，根據聯交所最新權益披露資料顯示，2022年1月4日，藥明生物(02269.HK)獲JPMorgan Chase & Co.以每股均價81.4074港元增持好倉279.129萬股，涉資約2.27億港元。

增持後，JPMorgan Chase & Co.最新持好倉數目為213,219,174股，持好倉比例由4.94%上升至5.00%。

药明生物(02269.HK)

Relevant Stocks

药明生物(02269.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

藥明生物(02269.HK)獲摩根大通增持279.13萬股

Services

About Us

Agreement Statement